Screening individuals for lung cancer with low-dose CT on a nonrisk basis is associated with a marked reduction in lung cancer mortality and better overall survival, reveals Chinese data.

New evidence from a Chinese cohort presented at the European Lung Cancer Congress (ELCC) 2026 shows that one-time low-dose ...

Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...

The impact of adverse financial events on healthcare utilization and treatment costs at the end of life. Guideline-concordant use of olanzapine as part of a 4-drug antiemetic regimen for high emetic ...

Please provide your email address to receive an email when new articles are posted on . Next-generation technologies and diagnostic tests offer the promise of improved cancer care, but they also ...

In the Crain’s Cleveland Business article, “CWRU, University Hospitals are part of a $3 million grant project on lung cancer, immunotherapy”, writer Rachel Abbey McCafferty highlights CCIPD’s role in ...

Significant research funding in the form of a five-year, $12.1 million U19 Grant from the National Institutes of Health (NIH) has been awarded to a collaboration of research teams co-led by ...